Categories Cannabis, Earnings

What to expect from Aurora Cannabis Q4 earnings

Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB) is slated to report its fourth-quarter results on September 11 after the bell followed by a conference call next day. The company believes it is inching closer towards profitability as strong revenue, patient and production growth, disciplined cost management, and high-tech production could drive higher growth.

Market analysts expect the company’s high margin advantage will drive profitability and cash flows for the future. The company’s consumer market cannabis sales will continue to drive the top line fueled by additional production capacity and available supply from its Aurora Sky, MedReleaf Markham and Bradford facilities.

However, the oil and extract-based sales will continue to fall due to oil extraction capacity constraints coupled with increasing production and sale of other cannabis products. The demand for the oil and extract-based products to increase as the Canadian consumer market evolves.

On Wednesday, Aurora announced the sale of balance 28.83 million shares in The Green Organic Dutchman for aggregate gross proceeds of $86.5 million. The company’s interest in The Green Organic Dutchman became less important to its core strategy when it acquired Whistler Medical Marijuana Corp.

Analysts expect the company to report revenue of $79.02 million for the fourth quarter. This is better than the previous year quarter’s revenue of $19.15 million. Meanwhile, the company expects fourth-quarter net revenues in the range of $100 million to $107 million.

Read: Zscaler Q4 earnings preview

For the third quarter, the company reported a wider loss due to higher costs and expenses. Net revenue soared by 305% year-over-year due to the cannabis production capacity added by Aurora Sky and MedReleaf’s Markham and Bradford facilities. In Q3 2019, Aurora produced 15,590 kilograms of cannabis compared to 1,206 kilograms in the prior-year quarter.

For the fourth quarter, Aurora expects net cannabis revenue in the range of $90 million to $95 million. The growth is anticipated to be across all key business segments including medical, both Canadian and international, and consumer markets. Production available for sale is expected to be at the upper end of the 25,000 to 30,000 kilograms range.

We’re on Apple News! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

AVGO Earnings: All you need to know about Broadcom Q1 2021 earnings results

Broadcom Limited (NASDAQ: AVGO) reported first quarter 2021 earnings results today. Total revenue increased 14% year-over-year to $6.65 billion. GAAP net income was $1.3 billion, or $3.05 per share, compared

Infographic: Costco (COST) Q2 2021 sales up 15%; earnings miss

Retail giant Costco Wholesale Corporation (NASDAQ: COST) reported higher earnings and revenues for the second quarter of 2021. Earnings missed analysts’ expectations, while sales beat. Net profit was $951 million

Will shifting to as-a-service model help Hewlett Packard in emerging stronger from COVID?

With the corporate world rapidly shifting to cloud-native computing after the virus outbreak changed work culture and the way businesses operate, technology providers are aggressively innovating their offerings. Hewlett Packard

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top